glp 1 wegovy FDA approves pill and changes everything about GLP-1 drugs Novo Nordisk launches its Wegovy

10.1523/jneurosci.1380-04.2004 J

Tirzepatide is an agonist at both the GIPR and GLP-1R and is a highly effective treatment for type 2 diabetes and obesity 3,4

These prespecified analyses considered factors such as age, hypertension, heart failure, eGFR, proteinuria, new users after the index day, enrollee after 2006 and concurrent usage of other medications for glycemic control, and renin-angiotensin-aldosterone system (RAAS) blockers

By eating enough protein, building muscle, managing side effects, and caring for your mental health, youll create a strong foundation for health that lasts for a lifetime

Injection Guidance Simple, once-weekly injections with clear instruction for at-home use